Senores Pharmaceuticals Share Price
14 Aug, 2026 3:52 PM (IST)
Senores Pharmaceuticals Performance
- Today's Low
- ₹1,470
- Today's High
- ₹1,510
- 52 Week Low
- ₹662
- 52 Week High
- ₹1,515
- Open Price₹1,491
- Previous Close₹1,491
- Volume105,560
- 50 DMA₹1,316.50
- 100 DMA₹1,184.10
- 200 DMA₹1,018.90
Senores Pharmaceuticals Chart
Investment Returns
- Over 1 Month + 1.78%
- Over 3 Month + 54.79%
- Over 6 Month + 88.59%
- Over 1 Year + 118.84%
Smart Investing Starts Here Start SIP with Senores Pharmaceuticals for Steady Growth!
Senores Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 53.9
- PEG Ratio
- 0.6
- Market Cap Cr
- 6,805
- P/B Ratio
- 7.3
- Average True Range
- 56.4
- EPS
- 27.4
- Dividend Yield
- 0
- MACD Signal
- 35
- RSI
- 64.5
- MFI
- 49.37
Latest Stock News Updates
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dhananjay Barot
- BSE India
- 2 days 22 hours ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashokkumar Vijaysinh Barot
- BSE India
- 2 days 22 hours ago
Senores Pharmaceuticals Limited has informed the Exchange regarding the Scrutinzer Report dated August 04, 2026
- BSE India
- 1 week 3 days ago
Senores Pharmaceuticals Financials
Senores Pharmaceuticals Technicals
EMA & SMA
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹1,398.90
- 50 Day
- ₹1,316.50
- 100 Day
- ₹1,184.10
- 200 Day
- ₹1,018.90
Resistance and Support
- R3 1,541.50
- R2 1,525.70
- R1 1,501.70
- S1 1,461.90
- S2 1,446.10
- S3 1,422.10
Senores Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-07-27 | Quarterly Results | |
| 2026-05-14 | Audited Results | |
| 2026-01-20 | Quarterly Results & Others | To consider other business matters. |
| 2026-01-07 | Others | Inter alia, 1. To consider and evaluate proposals for raising funds by way of issue of convertible warrants on preferential basis to the promotors/promoter group. |
| 2025-11-06 | Quarterly Results |
About Senores Pharmaceuticals
Senores Pharmaceuticals is engaged in the business of manufacturing, marketing and trading of pharmaceuticals and allied products and also providing management and consultancy services. View More- NSE Symbol
- SENORES
- BSE Symbol
- 544319
- ISIN
- INE0RB801010
Similar Stocks to Senores Pharmaceuticals
Popular Stocks
Senores Pharmaceuticals FAQs
Senores Pharmaceuticals share price is ₹1,477 As on 15 August, 2026 | 13:59
The Market Cap of Senores Pharmaceuticals is ₹6805.3 Cr As on 15 August, 2026 | 13:59
The P/E ratio of Senores Pharmaceuticals is 53.9 As on 15 August, 2026 | 13:59
The PB ratio of Senores Pharmaceuticals is 7.3 As on 15 August, 2026 | 13:59
The 52 week High & Low of Senores Pharmaceuticals is ₹1514.8/₹662.4 respectively As on 15 August, 2026 | 13:59
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.